McAdam LLC’s MiMedx Group MDXG Stock Holding History

McAdam LLC’s Portfolio MDXG Stock Details MDXG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-1,900	Closed	-$12K	–	396
2018 Q3	$12K	Buy	+1,900	New	+$8.59K	﹤0.01%	319

Other funds holding MDXG

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

Manulife (Manufacturers Life Insurance) Canada, Ontario, Canada $116B AUM 26.37% 1-Year Est. Return

DGI

Disciplined Growth Investors Minneapolis, Minnesota $4.89B AUM 33.85% 1-Year Est. Return

California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return

TIM

Thompson Investment Management Madison, Wisconsin $872M AUM 35.59% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

WMC

Westwood Management Corporation Chicago, Illinois $270M AUM 54.59% 1-Year Est. Return

PAM

Pegasus Asset Management Montebello, New York $313M AUM 24.74% 1-Year Est. Return

MWNA

Marshall Wace North America New York $23.5B AUM 46.46% 1-Year Est. Return

McAdam LLC's MDXG Position: Q4 2018 in Review

McAdam LLC sold out of MiMedx Group (MDXG) in Q4 2018, closing a stake of 1,900 shares — an estimated $12K sold.

McAdam LLC first reported a position in MDXG in Q3 2018 and held it in 1 quarter. The position peaked at $12K in Q3 2018. 38 funds tracked by Wall St. Rank hold MDXG as of Q4 2018.

McAdam LLC reported no remaining MiMedx Group position as of Q4 2018 after selling out during the quarter.
McAdam LLC sold 1,900 MiMedx Group shares in Q4 2018, an estimated $12K.
McAdam LLC first reported a position in MiMedx Group in Q3 2018 and held it in 1 quarter.
McAdam LLC's MiMedx Group position peaked at $12K in Q3 2018.
38 funds tracked by Wall St. Rank held MiMedx Group as of Q4 2018.

Based on McAdam LLC's 13F filing for Q4 2018, filed 30 Jan 2019.